Literature DB >> 6967876

Subpopulations of circulating B cells and regulatory T cells involved in in vitro immunoglobulin E production in atopic patients with elevted serum immunoglobulin E.

A Saxon, C Morrow, R H Stevens.   

Abstract

The B lymphocyte subpopulations producing immunoglobulin (Ig)E and the regulatory T cells modulating this IgE production in normals, and in atopic patients with respiratory allergy, atopic dermatitis, and markedly elevated serum IgE levels (>5,000 ng/ml), were investigated. Peripheral blood lymphocytes (PBL) were separated into T and B cell fractions and the ability of B cells to produce IgE in the presence or absence of pokeweed mitogen (PWM) and/or T cells ws determined. The patients had a circulating population of cells which spontaneously produced up to 6 ng of IgE in vitro (per 4 X 10(5) non-E-rosetting cells) in the absence of T lymphocytes and PWM. PBL from normals did not possess such cells. This IgE synthesis occurred primarily (>75%) over the first 72 h of culture. There was a wide range in their activity between patients and from the same patient studied on repeated occasions (from <300 to 6,000 pg per culture). This spontaneous IgE production was inhibited by PWM (mean inhibition, 37%) or normal T lymphocytes (mean inhibition, 42%). The patients lacked T lymphocytes capable of inhibiting this spontaneous IgE synthesis in 7 of 13 experiments. Functionally distinct B cells were identified in the patients and normals that responded to PWM with IgE production in vitro and required T-helper cell activity. Patients had normal PWM-responsive B cell IgE biosynthetic activity and T-helper function for these B cells. Suppressor T cell activity for PWM-driven IgE synthesis was also evaluated. Both the normals' and the patients' T lymphocytes provided similar levels of T cell suppressor function for PWM-driven IgE production. Patients with elevated serum IgE possessed these inhibitory T cells at times when the T lymphocytes which suppressed spontaneous igE production were absent from their PBL.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967876      PMCID: PMC371484          DOI: 10.1172/JCI109810

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Enumerating immunoglobulin-secreting cells among peripheral human lymphocytes. A hemolytic plaque assay for a B cell function.

Authors:  W C Eby; C A Chong; S Dray; G A Molinaro
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  In vitro production of IgE by human peripheral blood lymphocytes: effect of cholera toxin and beta adrenergic stimulation.

Authors:  R Patterson; I M Suszko; W J Metzger; M Roberts
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

3.  Enhancement by irradiated T cells of human plasma cell production: dissection of helper and suppressor functions in vitro.

Authors:  F P Siegal; M Siegal
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

4.  Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer.

Authors:  A Saxon; J Portis
Journal:  Cancer Res       Date:  1977-04       Impact factor: 12.701

Review 5.  Cellular events in the IgE antibody response.

Authors:  K Ishizaka
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

Review 6.  Regulation of reaginic antibody formation in animals.

Authors:  T Tada
Journal:  Prog Allergy       Date:  1975

7.  Biology of immunoglobulin E. Molecular basis of reaginic hypersensitivity.

Authors:  T Ishizaka; K Ishizaka
Journal:  Prog Allergy       Date:  1975

8.  Single step separation of human T and B cells using AET treated srbc rosettes.

Authors:  A Saxon; J Feldhaus; R A Robins
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

9.  Analysis of parameters affecting the solid phase radioimmunoassay quantitation of antibody to meningococcal antigens.

Authors:  W D Zollinger; J M Dalrymple; M S Artenstein
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

10.  Antipolysaccharide antibodies of restricted heterogeneity secreted by a single lymph node.

Authors:  H Frost; D G Braun; D Poskitt; R N Cahill; Z Trnka
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

View more
  40 in total

Review 1.  Regulation of IgE synthesis in humans.

Authors:  D Vercelli; R S Geha
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

Review 2.  Human IgE biosynthesis in vitro.

Authors:  G Del Prete; E Maggi; S Romagnani; M Ricci
Journal:  Clin Rev Allergy       Date:  1989

Review 3.  Genetic control of IgE immune response.

Authors:  S Matsushita; T Sasazuki
Journal:  Clin Rev Allergy       Date:  1989

4.  Antisera to human IgE can also recognize IgA and IgM molecules as produced by selected B lymphoblastoid cell lines.

Authors:  R W Hendriks; A Thompson; M E Kraakman; A L Drayer; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

Review 5.  Current status of allergen immunotherapy (hyposensitization): memorandum from a WHO/IUIS meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

6.  Cytokine regulation of antigen-driven immunoglobulin production in filarial parasite infections in humans.

Authors:  C L King; E A Ottesen; T B Nutman
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

Review 7.  Immunoregulatory abnormalities in atopic dermatitis.

Authors:  D Y Leung; R S Geha
Journal:  Clin Rev Allergy       Date:  1986-02

8.  Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma.

Authors:  C L King; J I Gallin; H L Malech; S L Abramson; T B Nutman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Role of T gamma cells in the in vitro IgE response after antigenic stimulation.

Authors:  C Vela; R Garcia; L Tricas; C Platas; C Lahoz
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

10.  Specificity of immunoglobulin E in coccidioidomycosis and correlation with disease involvement.

Authors:  R A Cox; B S Baker; D A Stevens
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.